phase I study of 99mTc-h-R3 monoclonal antibody (DiaCIM ®), a humanized monoclonal antibody (mAB) for imaging EGFR-positive malignancies.

Reilly RM., Vallis K., Chen P., Oza A., Hendler A., Cameron R., Hershkop M., Keene P.

Type

Journal article

Publication Date

2002-01-01T00:00:00+00:00

Volume

43

Pages

311P - 312P

Permalink Close